• Home
• Conference Coverage
• Event Calendar
• UroToday International Journal
• Advanced Search

Search    Display 5 10 15 20 25 30 50 results per page Results 1 - 8 of 8 << Start < Prev 1 Next > End >> European Urology - The Metabolic Syndrome and Erectile Dysfunction: Multiple Vascular Risk Factors and Hypogonadism Tuesday, 29 August 2006 Volume 50, Issue 3, Pages 426-427 (September 2006) In this issue Corona and colleagues conclude that erectile dysfunction (ED) is more severe in patients with the metabolic syndrome and associated with an increased incidence of hypogonadism [1]. The findings have important lifestyle, prevention, and therapeutic implications. read more European Urology - Adherence to the Right Diagnostic Tools for Best Outcomes in Urethral Reconstructive Surgery Tuesday, 29 August 2006 Volume 50, Issue 3, Pages 424-425 (September 2006) Collecting the right preoperative clinical and radiologic investigations is pivotal to perform urethral reconstructive surgery and improve the short and long-term outcomes. The term “urethral stricture” refers to different pathologies with regard to anatomy, etiology, pathology, radiology, and surgery, and urologists are used to including, in the urethral stricture category, different conditions such as lichen sclerosus, failed hypospadias repair, and pelvic trauma [1]. read more European Urology - Reflections on a New Artificial Urinary Sphincter Tuesday, 29 August 2006 Volume 50, Issue 3, Pages 421-423 (September 2006) Before the early 1970s the treatment of urinary incontinence owing to intrinsic sphincteric deficiency, particularly in men with this problem after prostatectomy, posed a nearly insurmountable challenge. read more European Urology - Lasers for the Treatment of Bladder Outlet Obstruction: Are They Challenging Conventional Treatment Modalities? Tuesday, 29 August 2006 Volume 50, Issue 3, Pages 418-420 (September 2006) Benign prostatic hyperplasia (BPH) is the most common benign neoplasm among aging men and, at the same time, the most frequent male tumor requiring surgical intervention. Transurethral resection of the prostate (TURP) still remains the “reference” instrumental treatment for benign prostatic obstruction, but the significant morbidity related to this surgical procedure has powered the development of various high-energy alternative treatment options. read more European Urology - Medical Management of BPH: The Debate Continues Tuesday, 29 August 2006 Volume 50, Issue 3, Pages 416-417 (September 2006) After more than 15 years of extensive clinical research in the medical management of BPH one would expect that it has now become clear how to treat. read more European Urology - Micronutrients and BPH Tuesday, 29 August 2006 Volume 50, Issue 3, Pages 413-415 (September 2006) Descriptive epidemiology suggests that the incidence and prevalence of prostatic diseases vary significantly in different areas of the world [1], [2], [3]. Possible reasons for such wide variations have been explored and nutritional factors were found to play a role together with genetic, behavioral, occupational, and environmental ones. read more European Urology - Watching the Face of Janus – Active Surveillance as a Strategy to Reduce Overtreatment for Localised Prostate Cancer Tuesday, 29 August 2006 Volume 50, Issue 3, Pages 410-412 (September 2006) Prostate cancer is a disease with the two faces of Janus: having one benevolent face of small, indolent tumours, abundant among middle-aged and elderly men, it also has the grim face of a great killer, being the second most common cancer-related cause of death within the European Union and in the United States [1], [2]. read more European Urology - Testosterone Deficiency Syndrome (TDS) Needs to be Named Appropriately – The Importance of Accurate Terminology Tuesday, 29 August 2006 Volume 50, Issue 3, Pages 407-409 (September 2006) The decline in androgen production in association with increasing age has been recognized and documented for decades [1]. The prevalence and incidence of the condition has been estimated [2] and its treatment is becoming established [3]. Controversy however still exists on the clinical relevance of diminishing plasma testosterone (T) levels [4]. read more   << Start < Prev 1 Next > End >> Results 1 - 8 of 8

UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810 About The Editors | About Us | Contact Us | Report an Inaccuracy | Sponsorship Opportunities | Terms of Use Privacy Policy | © 2009 UroToday ® All Rights Reserved